Curious how GLP‑1 agonists fit into holistic dermatology care? Don’t miss this rapid-fire, 25‑minute panel in the Opening General Session at ODAC 2026 (Jan 16):
“GLP‑1 Agonists in Cutaneous Medicine: Rapid‑Fire Insights on Comorbidities, Safety, and Aesthetic Considerations”
Moderator: Adam Friedman, MD, FAAD
Panelists: Jennifer Soung, MD, FAAD; Steven Daveluy, MD, FAAD; Sarah Jackson, MD, FAAD
What to expect:
– Focused review of metabolic and inflammatory comorbidities in psoriasis and HS
– Practical evidence and tips for integrating GLP‑1 therapy to address cardiometabolic risk
– Discussion of potential aesthetic consequences (hair changes, skin laxity) and safety monitoring
– Multidisciplinary strategies you can use in clinic
This concise, discussion‑driven session is ideal for dermatologists, trainees, and multidisciplinary colleagues wanting actionable, real‑world guidance. See you there!
(Are you just now thinking about ODAC? Don’t miss out: Register today!)
